Vaccine Pros vs. Cons

A balanced analysis of documented benefits and risks.

How to Read This Page

This page presents documented benefits and risks of vaccination based on peer-reviewed research and regulatory agency data. This is not advocacy—it is a summary of what scientific evidence shows.

Documented Benefits

Documented Risks

All vaccines carry some risk of adverse events. Most are mild and temporary, but serious events do occur at low rates. The following risks are documented in peer-reviewed literature and regulatory agency data.

Common mild reactions (very frequent):

  • • Injection site soreness, redness, or swelling
  • • Fatigue, headache, or low-grade fever
  • • These typically resolve within 1–3 days

Rare but serious adverse events (documented):

  • Anaphylaxis (severe allergic reaction): ~1–2 per million doses across most vaccines
  • Febrile seizures: associated with MMR and MMRV vaccines in young children; generally self-limiting with no long-term effects
  • Myocarditis/pericarditis: documented primarily in young males following mRNA COVID-19 vaccines; most cases mild and resolve without treatment
  • Intussusception: historically linked to the original RotaShield rotavirus vaccine (withdrawn 1999); monitored in current rotavirus vaccines
  • Guillain-Barré Syndrome: small elevated risk documented with some influenza vaccines; risk ~1–2 additional cases per million doses
  • Thrombosis with Thrombocytopenia Syndrome (TTS): rare risk documented with adenoviral vector COVID-19 vaccines (J&J/Janssen, AstraZeneca); contributed to restricted use

Ongoing monitoring:

  • • Post-market surveillance systems (VAERS, Yellow Card, EudraVigilance) continuously monitor for new signals
  • • ACIP benefit-risk frameworks reassess vaccines as new data emerges
Learn more about known adverse events →

Sources